Chi­nese phar­ma pow­er­house Han­soh joins fledg­ling biotechs in the Hong Kong IPO line

More than four months af­ter first open­ing its doors to a big crowd of R&D fo­cused biotechs, the Hong Kong Stock Ex­change has seen a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.